Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy.

Yu ZhouShasha WangYunxia TaoHaizhu ChenYan QinXiaohui HeShengyu ZhouPeng LiuJianliang YangSheng YangLin GuiNing LouZhishang ZhangJiarui YaoXiaohong HanYuan-Kai Shi

Published in: Journal of translational medicine (2021)

CCL19 expression was associated with survival outcomes and might be a potential prognostic biomarker for FL treated with first-line chemoimmunotherapy.

Keyphrases

poor prognosis
liver injury
liver fibrosis
binding protein
emergency department
newly diagnosed